Changes, there are several thousand pages of clinical studies and articles in Journals like NEJM about VASCEPA! It has been clinically proven to reduce strokes, heart attacks etc. by 35 to 40 % dependent on the length of time it is taken - it gets better the longer it is in use - and most importantly in you case it is also called the liquid stent as it reduces plaque in coronary blood vessels by up to 65 % within 6 months!
What maybe most important for your Mom's condition is that it does work as a powerful anti-inflammatory agent almost rightaway.
For those reasons KAISER PEMANENTE is doing a trial on some 16.000 cardio patients that already receive the medication on how it fairs for them re:COVID19 . Since this is highly relevant for anyone interested in how to combat COVID19 I will try to produce a short dossier sometime next week if you are interested
News 
Market Data 
Discover 
